1
The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
Condition(s):Resectable Pancreatic Ductal AdenocarcinomaLast Updated:January 18, 2018Not yet recruiting
Metformin Hydrochloride: 2386 Clinical Trials, Page 1 of 239
Hide Studies Not Open or Pending
2
Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study
Condition(s):HealthyLast Updated:November 25, 2019Completed
3
Pharmacokinetics of Metformin Intolerance
Condition(s):Diabetes Mellitus, Type 2; Metformin Adverse ReactionLast Updated:December 5, 2017Completed
4
Metformin in Children and Adults With Fragile X Syndrome
Condition(s):Fragile X SyndromeLast Updated:October 26, 2018Recruiting
5
A Study to Evaluate the Efficacy and Safety of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With Type 2 Diabetes Mellitus
Condition(s):Type 2 Diabetes MellitusLast Updated:January 7, 2020Not yet recruiting
6
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
Condition(s):Oral CancerLast Updated:September 26, 2018Recruiting
7
Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
Condition(s):Type 1 Diabetes Mellitus; MetforminLast Updated:July 20, 2018Recruiting
8
Metformin Therapy in HCV Infection
Condition(s):Chronic Hepatitis C InfectionLast Updated:November 23, 2016Completed
9
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
Condition(s):Age-Related Macular Degeneration; Macular Degeneration, Age-Related; Dry Macular Degeneration; Geographic AtrophyLast Updated:January 29, 2019Recruiting
10
Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
Condition(s):Type2 DiabetesLast Updated:August 8, 2019Not yet recruiting